Aurora Cannabis (ACB) EPS (Weighted Average and Diluted) (2020 - 2025)

Aurora Cannabis (ACB) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.02 in Q4 2025.

• EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.02, down 94.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.45 (up 161.54% YoY), and the FY2025 annual result was $0.03, up 102.47% from the prior year.
• EPS (Weighted Average and Diluted) eased to $0.02 in Q4 2025 per ACB's latest filing, from $0.66 in the prior quarter.
• Over five years, EPS (Weighted Average and Diluted) peaked at $3.73 in Q1 2022 and troughed at -$6.21 in Q2 2021.
• A 5-year average of -$0.09 and a median of $0.04 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
• On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 2155.08% in 2025 and fell as far as 94.22% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.3 in 2021, then surged by 146.43% to $0.14 in 2022, then sank by 73.76% to $0.04 in 2023, then surged by 913.54% to $0.37 in 2024, then sank by 94.22% to $0.02 in 2025.
• Business Quant data shows ACB's EPS (Weighted Average and Diluted) at $0.02 in Q4 2025, $0.66 in Q3 2025, and $0.19 in Q2 2025.